Home › Peripheral Arterial Disease › Colorado
Peripheral Arterial Disease clinical trials in Colorado
7 studies for Peripheral Arterial Disease are looking for participants at sites in Colorado.
Cities in Colorado
The THOR IDE Study
- Rocky Mountain Regional VA Medical Center, Aurora
Recruiting
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT05916950Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- Rocky Mountain Regional VA Medical Center, Aurora
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07223593Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Western Nephrology, Arvada
- Kidney Associates of Colorado, P.C., Denver
- Colorado Kidney Care, Denver
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
- Denver Health and Hospital Authority, Denver
Recruiting
Ages 18 and older · All sexes · Updated May 13, 2026 · NCT05811364Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease
- Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora
Recruiting
Ages 21 and older · All sexes · Updated May 6, 2026 · NCT06033924Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic Cardiovascular Disease
- University of Colorado Health System (UCHealth), Aurora
Recruiting
Ages 18 and older · All sexes · Updated Jan 23, 2026 · NCT07334834Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Dec 17, 2025 · NCT02915198From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.